Sciencast Management LP Has $1.32 Million Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Sciencast Management LP boosted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 236.3% during the 4th quarter, HoldingsChannel reports. The fund owned 69,276 shares of the medical instruments supplier’s stock after acquiring an additional 48,676 shares during the quarter. Sciencast Management LP’s holdings in DENTSPLY SIRONA were worth $1,315,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the stock. Xponance Inc. lifted its position in DENTSPLY SIRONA by 7.3% in the 4th quarter. Xponance Inc. now owns 33,034 shares of the medical instruments supplier’s stock valued at $627,000 after acquiring an additional 2,235 shares in the last quarter. Counterpoint Mutual Funds LLC bought a new stake in DENTSPLY SIRONA in the 4th quarter valued at $299,000. Signaturefd LLC lifted its position in DENTSPLY SIRONA by 513.3% in the 4th quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier’s stock valued at $84,000 after acquiring an additional 3,706 shares in the last quarter. Royce & Associates LP bought a new stake in DENTSPLY SIRONA in the 4th quarter valued at $220,000. Finally, Envestnet Portfolio Solutions Inc. lifted its position in DENTSPLY SIRONA by 82.9% in the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 15,901 shares of the medical instruments supplier’s stock valued at $302,000 after acquiring an additional 7,206 shares in the last quarter. 95.70% of the stock is owned by institutional investors.

Insider Activity

In related news, Director Gregory T. Lucier purchased 15,142 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.52% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities research analysts recently commented on XRAY shares. Robert W. Baird cut their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating on the stock in a research report on Friday, February 28th. Barrington Research cut their price target on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research report on Friday, February 28th. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Morgan Stanley cut their price target on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th. Finally, StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday, February 28th. Twelve research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, DENTSPLY SIRONA currently has an average rating of “Hold” and a consensus price target of $23.33.

View Our Latest Report on XRAY

DENTSPLY SIRONA Stock Down 0.3 %

Shares of XRAY stock opened at $15.56 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The firm’s 50-day moving average is $17.92 and its 200-day moving average is $20.50. The stock has a market cap of $3.10 billion, a price-to-earnings ratio of -7.52, a PEG ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a 52-week low of $14.78 and a 52-week high of $33.42.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be issued a $0.16 dividend. The ex-dividend date is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.11%. DENTSPLY SIRONA’s payout ratio is -14.07%.

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.